Insider trade

Zoetis (ZTS): Executive Vice President received 237.64 units

Rimma Driscoll, Executive Vice President at Zoetis, reported a grant / award of 237.64 units.

237.64
Derivative units · @ $26.22
Traded
Jul 10, 2026
Filed
Jul 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 11, 2026Insider · 9 days before an 8-KDirector purchased ~$233K of ZTS shares in the open market
  2. May 13, 2026Insider · 2 peopleInsiders: 2 purchases (~$653K)
  3. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.”
  4. May 27, 2026Court · District Court, S.D. New YorkSecurities lawsuit filed: City of Ann Arbor Retiree Health Care Benefit Plan & Trust v. Zoetis Inc.
  5. Jun 9, 2026Congress · 1 personMembers of Congress: 2 purchases
  6. Jun 16, 2026CongressDisclosed purchase of ZTS — reported range $1,001 - $15,000
  7. Jul 8, 2026Federal contract · $251 obligatedDepartment of Defense awarded Zoetis: $251 obligated to date

What came next

  1. Jul 17, 2026CongressDisclosed partial sale of ZTS — reported range $1,001 - $15,000
  2. Jul 30, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 9.0%
  3. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 6, 2026, Zoetis Inc. (the “Company”) announced that James Saccaro has been appointed as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.”
  5. Aug 31, 2026Government · Federal Register noticeAuthorization of Emergency Use for Three Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
  6. Sep 14, 2026Federal contract · $35K obligatedDepartment of Health and Human Services awarded Zoetis: $35K obligated to date
  7. Sep 18, 2026CongressDisclosed purchase of ZTS — reported range $1,001 - $15,000
  8. Oct 8, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 8, 2026, the Board of Directors (the "Board") of Zoetis Inc. (the “Company”) appointed Iris Knobloch to the Board, effective as of December 1, 2026, to serve in such capacity until her successor is appointed or qualified or until her resignation or removal.”
  9. Oct 15, 2026Government · Federal Register noticeAuthorization of Emergency Use for Four Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
  10. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zoetis

For Zoetis, OQRO holds 4 Congress trade reports, 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZTS page.

How this filing works

Explore the data

Common questions

Which Zoetis (ZTS) insider traded, and how much?

Rimma Driscoll, Executive Vice President at Zoetis, reported a grant / award of 237.64 units. At $26.22.

When did it happen, and when was it made public?

Traded: Jul 10, 2026. Filed: Jul 14, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Zoetis recently?

For Zoetis, OQRO holds 4 Congress trade reports, 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the ZTS page.

Does this mean ZTS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Zoetis

Everything OQRO holds on this company is on its ZTS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data